Logotype for agilon health inc

agilon health (AGL) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for agilon health inc

Proxy filing summary

23 Apr, 2026

Executive summary

  • The annual meeting is scheduled for June 2, 2026, with voting on director elections, auditor ratification, and executive compensation approval.

  • The company emphasizes its Total Care Model, focusing on value-based care for seniors, quality outcomes, and operational efficiency.

  • Leadership transitioned in 2025, with the CEO resigning and the Executive Chairman assuming interim leadership, supported by a strengthened executive team.

  • The company faced profitability pressures in 2025 but responded with strategic actions to restore financial strength and prioritize margin over membership growth.

  • Proxy materials are delivered electronically to reduce costs and environmental impact.

Voting matters and shareholder proposals

  • Stockholders will vote on electing three Class II directors for three-year terms, ratifying Ernst & Young LLP as auditor, and an advisory say-on-pay vote for executive compensation.

  • The board recommends voting FOR all proposals.

Board of directors and corporate governance

  • The board consists of seven members, classified into three staggered terms; three Class II directors are up for election.

  • The board is majority independent, with robust governance guidelines, codes of conduct, and annual board evaluations.

  • The Executive Chairman leads the board during the CEO transition, with flexibility in leadership structure.

  • Committees include Audit, Compensation and Human Capital, Nominating and Governance, and Compliance and Quality, each with defined oversight roles.

  • Director compensation includes cash and equity, with annual RSU grants and committee chair retainers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more